Skip to main content
SupplementScience
Boswellia supplement
Herbal Extract

Boswellia: Benefits, Dosage, Forms & Research

Herbal Extract

This content is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any supplement. Full disclaimer

TL;DR — Quick Answer

Boswellia serrata extract (standardized to AKBA) at 300-500mg daily reduces joint pain and inflammation by inhibiting 5-LOX enzyme. Clinical trials show significant improvement in osteoarthritis symptoms within 1-2 weeks. Choose extracts standardized to ≥30% boswellic acids.

Key Facts

What it is
A resin extract from Boswellia serrata containing boswellic acids, primarily AKBA
Primary benefits
  • Inhibits 5-lipoxygenase (5-LOX) enzyme
  • Reduces osteoarthritis pain and stiffness
  • May benefit inflammatory bowel disease
  • Does not cause GI ulceration like NSAIDs
Typical dosage
300-500mg daily (standardized to ≥30% boswellic acids)
Evidence level
Moderate
Safety profile
Generally Safe

What the Research Says

Boswellia serrata has been used in Ayurvedic medicine for centuries and now has substantial clinical evidence. A 2020 meta-analysis by Yu et al. (7 RCTs, n=545) confirmed significant improvements in pain and physical function for knee osteoarthritis. The patented Aflapin extract showed particularly rapid results, with significant improvements within 5-7 days (Sengupta et al., 2010). Mechanistically, AKBA directly inhibits 5-lipoxygenase, blocking leukotriene B4 and other pro-inflammatory mediators. Early research also supports benefits for inflammatory bowel disease and asthma. Boswellia is notable for its GI-sparing profile compared to NSAIDs, making it a promising alternative for long-term inflammatory condition management.

Benefits of Boswellia

  • Osteoarthritis relief — a 2020 meta-analysis (Yu et al., 7 RCTs, n=545) found boswellia significantly improved pain and function scores in knee OA patients compared to placebo
  • 5-LOX inhibition — AKBA (acetyl-11-keto-beta-boswellic acid) is a direct, non-competitive inhibitor of 5-lipoxygenase, blocking pro-inflammatory leukotriene synthesis
  • Fast onset — the Aflapin (enriched boswellia) trial (Sengupta et al., 2010, n=60) demonstrated significant pain reduction within 5-7 days of supplementation
  • GI-sparing profile — unlike NSAIDs, boswellia does not inhibit COX-1, which is protective of the gastric mucosa, making it safer for long-term use
  • IBD support — a pilot RCT (Gupta et al., 2001, n=34) found boswellia extract comparable to mesalazine for maintaining remission in ulcerative colitis
Did you know?

Boswellia serrata has been used in Ayurvedic medicine for centuries and now has substantial clinical evidence.

Forms of Boswellia

FormBioavailabilityBest For
Standard Boswellia Extract (65% boswellic acids)ModerateGeneral anti-inflammatory use — widely available and well-studied
Aflapin (enriched extract)HighFaster onset — shows effects within 5-7 days in clinical trials at 100mg/day
5-Loxin (30% AKBA)HighTargeted 5-LOX inhibition — concentrated AKBA for maximum enzyme inhibition

Dosage Recommendations

General recommendation: 300-500mg boswellia extract daily, standardized to ≥30% boswellic acids

Timing: Take with meals to enhance absorption of lipophilic boswellic acids • Take with food for best absorption.

Dosage by Condition

ConditionRecommended DoseEvidence
Osteoarthritis300-500mg standardized extract dailyModerate
Inflammatory bowel disease350mg three times daily (1,050mg/day)Emerging
Asthma300mg three times dailyPreliminary

Upper limit: Up to 1,200mg/day has been used in clinical trials without significant adverse effects

Side Effects and Safety

Safety profile: Generally Safe

Potential Side Effects

  • Mild gastrointestinal discomfort (nausea, acid reflux) in some users
  • Rare skin rash or allergic reaction
  • Diarrhea at high doses

Drug & Supplement Interactions

  • Anticoagulants — boswellia may have mild antiplatelet activity; monitor if combining with blood thinners
  • NSAIDs — additive anti-inflammatory effects; may allow NSAID dose reduction under medical supervision
  • Immunosuppressants — theoretical interaction due to immune-modulating effects
Check Boswellia interactions with other supplements →
BenefitsDosage GuideSide EffectsTypes & FormsResearchFAQ

Related Conditions

Inflammation

Related Supplements

Turmeric / CurcuminOmega-3 Fish OilGingerDevil's Claw

Frequently Asked Questions

What is AKBA and why is it important?

AKBA (acetyl-11-keto-beta-boswellic acid) is the most potent anti-inflammatory compound in boswellia. It directly inhibits the 5-LOX enzyme, blocking leukotriene production. Look for extracts standardized to at least 30% AKBA for maximum anti-inflammatory benefit.

How does boswellia compare to NSAIDs?

Boswellia inhibits 5-LOX (blocking leukotrienes) while NSAIDs inhibit COX enzymes (blocking prostaglandins). Boswellia does not cause the GI ulceration associated with NSAIDs. Clinical trials suggest comparable pain relief for mild-moderate osteoarthritis, though NSAIDs may be faster-acting for acute pain.

Can I take boswellia with turmeric?

Yes, boswellia and turmeric/curcumin target different inflammatory pathways (5-LOX vs. NF-kB/COX-2) and are commonly combined. Several commercial joint supplements combine both. No significant adverse interactions have been reported in clinical studies.

References

  1. (). Effectiveness of boswellia and boswellia extract for osteoarthritis patients: a systematic review and meta-analysis. BMC Complementary Medicine and Therapies. DOI
  2. (). A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee. Arthritis Research & Therapy. DOI
  3. (). Comparative efficacy and tolerability of 5-Loxin and Aflapin against osteoarthritis of the knee. International Journal of Medical Sciences. DOI